| S100B protein as a therapeutic target in multiple sclerosis: The S100B inhibitor arundic acid protects from chronic experimental autoimmune encephalomyelitis C Camponeschi, M De Carluccio, S Amadio, ME Clementi, B Sampaolese, ... International journal of molecular sciences 22 (24), 13558, 2021 | 23 | 2021 |
| Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface D Pirolli, B Righino, C Camponeschi, F Ria, G Di Sante, MC De Rosa Scientific Reports 13 (1), 1494, 2023 | 21 | 2023 |
| Recovering or persisting: the immunopathological features of SARS-CoV-2 infection in children D Buonsenso, P Valentini, C De Rose, M Tredicine, MC Pereyra Boza, ... Journal of Clinical Medicine 11 (15), 4363, 2022 | 16 | 2022 |
| Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis G Di Sante, E Gremese, B Tolusso, P Cattani, C Di Mario, S Marchetti, ... Frontiers in Medicine 8, 671018, 2021 | 14 | 2021 |
| A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis M Tredicine, C Camponeschi, D Pirolli, M Lucchini, M Valentini, ... Iscience 25 (2), 2022 | 13 | 2022 |
| Immunopathology of SARS-CoV-2 infection: A focus on T regulatory and B cell responses in children compared with adults G Di Sante, D Buonsenso, C De Rose, M Tredicine, I Palucci, F De Maio, ... Children 9 (5), 681, 2022 | 10 | 2022 |
| Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients M Tredicine, F Ria, N Poerio, M Lucchini, A Bianco, F De Santis, ... Biomaterials 292, 121930, 2023 | 6 | 2023 |
| Prediction of CD44 structure by deep learning-based protein modeling C Camponeschi, B Righino, D Pirolli, A Semeraro, F Ria, MC De Rosa Biomolecules 13 (7), 1047, 2023 | 4 | 2023 |
| Study of the effects of Lemna minor extracts on human immune cell populations CC Cardoso, E Miraldi, MR Ceccarini, Z Naureen, G Baini, E Manara, ... European Review for Medical and Pharmacological Sciences 25 (Supplemento 1 …, 2021 | 4 | 2021 |
| Liposome-based nanoparticles modulate Macrophage and regulatory T cell and effector phenotypes in Multiple Sclerosis patients A Pistilli, F Ria, M Tredicine, N Poerio, M Lucchini, C Camponeschi, ... Italian Journal of Anatomy and Embryology 126, 234-235, 2022 | 1 | 2022 |
| Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface D Pirolli, B Righino, C Camponeschi, F Ria, G Di Sante, MC De Rosa Scientific Reports 13, 2023 | | 2023 |
| The S100B protein as a therapeutic target for multiple sclerosis processes G Di Sante, C Camponeschi, M De Carluccio, S Amadio, ME Clementi, ... Italian Journal of Anatomy and Embryology 126, 160-161, 2022 | | 2022 |
| The use of arundic acid as novel therapy for multiple sclerosis F Michetti, C Camponeschi, S Amadio, B Sampaolese, ME Clementi, ... GLIA 69, E173-E174, 2021 | | 2021 |
Francesco RiaProfessore Associato, Università Cattolica del S. CuoreVerified email at unicatt.it
